On March 1, 2019, Peter O’Brien resigned from the board of directors of Artelo Biosciences, Inc. effective immediately. Mr. O’Brien’s resignation was for personal reasons and not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Mr. O’Brien will continue to serve in a leadership role in the European office of the Company and focus his efforts on operations management, investor relations and vertical liaising on behalf of the Company. Mr. O’Brien will also continue to serve on the board of directors for both fully-owned subsidiaries of the Company, Trinity Reliant Ventures Limited in Ireland and Trinity Research & Development Limited in the United Kingdom.